Roundup (glyphosate) is the world’s most widely used herbicide. Bayer/Monsanto faces over 165,000 claims alleging glyphosate causes non-Hodgkin’s lymphoma. The International Agency for Research on Cancer (IARC) classified glyphosate as "probably carcinogenic to humans" in 2015. Bayer established a $10.9 billion settlement program but litigation continues.
Non-Hodgkin lymphoma is the primary qualifying injury. Epidemiological studies show elevated NHL risk in agricultural workers with heavy glyphosate exposure. The IARC Group 2A classification is the causation anchor. Strongest cases involve regular direct exposure (farmers, landscapers) with documented NHL diagnosis.
Bayer is seeking court approval of a proposed $7.3B class settlement to resolve all remaining and future Roundup claims. The deal faces objections and a critical approval hearing is pending. If approved, this effectively closes the tort permanently. State court trials continue in the interim. Attorneys should finalize existing inventory and screen any remaining qualified leads immediately.